OXFORD, England--(BUSINESS WIRE)-- Oxford Nanopore Technologies Ltd. announces that Clive G Brown, Chief Technology Officer, will present at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, on 17th February 2012 at 11.40am (EST) \/ 4.40pm (GMT). <\/p>\n
The talk is titled: \u201cSingle Molecule \u2018Strand\u2019 Sequencing Using Protein Nanopores and Scalable Electronic Devices\u201d. <\/p>\n
Oxford Nanopore intends to commercialise DNA strand sequencing products, directly to customers within 2012. At the AGBT presentation, Oxford Nanopore will show DNA strand sequencing data and other disruptive features of the Company's proprietary electronics-based sensing devices. <\/p>\n
Further information will be provided at the time of the Company's presentation at the AGBT conference. <\/p>\n
-ends- <\/p>\n
Notes to editors <\/p>\n
Oxford Nanopore Technologies <\/p>\n
Oxford Nanopore Technologies Ltd is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable GridION technology platform is designed to offer substantial benefits in a variety of applications. <\/p>\n
The Company is developing two techniques for DNA sequencing: Strand Sequencing, and Exonuclease sequencing, both of which combine a protein nanopore with a processive enzyme for the analysis of DNA. The system is also compatible with the direct analysis of RNA. The Company has signed a commercialisation agreement for its exonuclease sequencing technology but not its strand sequencing technology which it intends to commercialise independently. Oxford Nanopore is also developing a Protein Analysis technology that combines target proteins with ligands for direct, electronic analysis using protein nanopores. These nanopore sensing techniques are combined with the Company's proprietary array chip within the GridION system. <\/p>\n
The Company is also developing the subsequent generation of nanopore sensing devices based on solid-state nanopores. <\/p>\n
Oxford Nanopore has licensed or owns more than 300 patents and patent applications that relate to many aspects of nanopore sensing including fundamental nanopore sensing patents, analysis using protein nanopores or solid state nanopores and for the analysis of DNA, proteins and other molecules. The Company has collaborations and exclusive licensing deals with leading institutions including the University of Oxford, Harvard and UCSC. Oxford Nanopore has funding programmes in these laboratories to support the science of nanopore sensing. This includes the use of functionalised solid-state nanopores for molecular characterisation, methods of fabricating solid-state nanopores and modifications of solid-state nanopores to adjust sensitivity or other parameters. <\/p>\n<\/p>\n
Excerpt from: OXFORD, England--(BUSINESS WIRE)-- Oxford Nanopore Technologies Ltd. announces that Clive G Brown, Chief Technology Officer, will present at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, on 17th February 2012 at 11.40am (EST) \/ 4.40pm (GMT). The talk is titled: \u201cSingle Molecule \u2018Strand\u2019 Sequencing Using Protein Nanopores and Scalable Electronic Devices\u201d. Continue reading
\nOxford Nanopore to Present DNA 'Strand Sequencing' Technology at AGBT Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"